Abhishek Jain - 02 Mar 2026 Form 3 Insider Report for NEOGENOMICS INC (NEO)

Role: Chief Financial Officer
Signature: /s/ Ali Olivo, Attorney-in-Fact
Issuer symbol: NEO
Transactions as of: 02 Mar 2026
Net transactions value: $0
Form type: 3
Filing time: 02 Mar 2026, 17:03:02 UTC
Previous filing: 05 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Jain Abhishek	Chief Financial Officer	9490 NEOGENOMICS WAY, FORT MYERS	/s/ Ali Olivo, Attorney-in-Fact	02 Mar 2026	0001931277

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NEO	Stock Option (Right to Buy)							02 Mar 2026	Common Stock	183,578	$13.74	Direct	F1
holding	NEO	Restricted Stock Unit							02 Mar 2026	Common Stock	110,088	$0.000000	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On January 13, 2026, Mr. Jain was granted 183,578 stock options. The options vest ratably over the first three anniversary dates of the grant date.
F2	On January 13, 2026, Mr. Jain was granted 110,088 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date.
F3	Once vested, the shares of common stock are not subject to expiration.